By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 116.78 |
Change Today | $ 3.20 |
% Change | 2.82 % |
52 Week High | $121.40 |
52 Week Low | $84.43 |
Volume | 8,712,575 |
Shares Issued | 1,246.00m |
Market Cap | $145,508m |
RiskGrade | 120 |
Time | Volume / Share Price |
15:59 | 100 @ $116.79 |
15:59 | 108 @ $116.80 |
15:59 | 100 @ $116.80 |
15:59 | 100 @ $116.80 |
15:59 | 100 @ $116.80 |
You are here: research